|
HS Code |
165019 |
| Name | Mesterolone |
| Brand Names | Proviron |
| Chemical Formula | C20H32O2 |
| Molecular Weight | 304.47 g/mol |
| Drug Class | Androgen; Anabolic steroid |
| Route Of Administration | Oral |
| Bioavailability | Approximately 3% |
| Cas Number | 1424-00-6 |
| Elimination Half Life | 12-13 hours |
| Primary Use | Treatment of male hypogonadism |
As an accredited Mesterolone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The Mesterolone packaging features a white label, bold black lettering, and contains 100 tablets, each tablet dosed at 25 mg. |
| Shipping | Mesterolone is shipped in compliance with international regulations for pharmaceuticals. It is securely packaged in sealed, tamper-evident containers to prevent contamination and degradation. The product is typically transported at controlled room temperature, accompanied by appropriate documentation and labeling, ensuring safe and legal delivery to authorized recipients only. |
| Storage | Mesterolone should be stored in a tightly closed container, protected from light and moisture. Keep it at room temperature, ideally between 20°C to 25°C (68°F to 77°F). Store in a secure, well-ventilated area away from incompatible substances and out of reach of children and unauthorized persons. Avoid exposure to extreme heat, humidity, or oxidative environments to maintain chemical stability. |
| Purity 99%: Mesterolone with purity 99% is used in pharmaceutical synthesis, where it ensures high bioavailability and consistent therapeutic performance. Melting Point 208°C: Mesterolone with a melting point of 208°C is used in solid oral dosage formulations, where it guarantees stable compound integration during tablet manufacturing. Molecular Weight 304.47 g/mol: Mesterolone with molecular weight 304.47 g/mol is used in pharmacological research, where it enables precise dosing calculations for clinical trials. Stability Temperature up to 40°C: Mesterolone with stability temperature up to 40°C is used in long-term storage facilities, where it maintains structural integrity and potency. Particle Size ≤50 µm: Mesterolone with particle size ≤50 µm is used in micronized drug preparations, where it promotes rapid dissolution and increased absorption rates. Assay ≥98%: Mesterolone with assay ≥98% is used in quality control laboratories, where it provides reliable analytical standards and reproducibility in test results. Residual Solvent ≤0.5%: Mesterolone with residual solvent ≤0.5% is used in injectable formulations, where it minimizes toxicity and meets regulatory requirements for safety. Water Content ≤0.1%: Mesterolone with water content ≤0.1% is used in anhydrous products, where it prevents hydrolytic degradation and prolongs shelf life. Specific Rotation +58° to +62°: Mesterolone with specific rotation +58° to +62° is used in chiral purity assessment, where it confirms stereochemical configuration accuracy. Heavy Metal Content ≤10 ppm: Mesterolone with heavy metal content ≤10 ppm is used in GMP manufacturing processes, where it ensures compliance with health standards and product safety. |
Competitive Mesterolone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In over two decades of continuous production across several active pharmaceutical ingredients, mesterolone remains an unrivaled staple in our synthesis lineup. Unlike newer compounds that demand elaborate pilot testing with every batch, the chemistry behind mesterolone has grown familiar to every technician on our team. We run its production from raw precursor all the way through fine crystallization and final packing under cGMP guidance. Most of us know its sensory properties even before analytical confirmation — bright white to off-white crystal powder, a certain tactile density, reliable melting point. These markers come from years watching this molecule grow from basic building blocks to batch lots moving out to specialty pharmaceutical firms.
Mesterolone, by chemical definition, is a synthetic androgen. Its structure shares close resemblance with dihydrotestosterone, but the chemistry gives it unique advantages in targeted applications. Where many synthetic androgens take cyclopentanoperhydrophenanthrene as a starting skeleton, mesterolone’s functional group orientation makes it suitable for oral formulations — a rare benefit in a field crowded with injectable profiles. The model we manufacture generally comes in the form of mesterolone base with no esterification, a deliberate choice that eliminates the need for hydrolysis by end users or secondary formulation adjustments downstream.
Handling mesterolone has its quirks. Its moderate solubility profile forces us to think carefully about crystallization rates and solvent choices. On the filter, too rapid cooling results in oversized aggregates; patience gives a fine, consistent powder with excellent blending characteristics. This matters for tablet lines, where flow rate and blend uniformity can mean the difference between a smooth tableting run and an equipment jam costing hours of downtime and wasted material.
We established in-process controls around particle size and purity years ago, after observing how small fluctuations at the synthesis stage could echo through to dissolution times in QC testing. In comparison to molecules with more forgiving tolerance windows, mesterolone keeps our teams on their toes. You can spot a well-made batch by its shine, the lack of off-odors, the way it pours from the storage drum.
Our clients, primarily pharmaceutical formulation houses and generic brands, favor mesterolone for its precise action profile. Unlike anabolic steroids broadly grouped as “non-specific enhancers,” mesterolone plays a cleaner role, typically in hormone replacement therapies that rely on the androgen pathway. Most importantly for oral solid dosage production, it stands out because of its strong stability at room temperature and compatibility with a wide range of conventional excipients.
We’ve followed the draft and finalized pharmacopoeia standards through each regulatory cycle. Mesterolone consistently demonstrates strong shelf stability; our own forced degradation studies routinely confirm retention of chemical potency far past the usual one-year checkpoint required for real-time analysis. This confidence supports long batch campaigns, saving resources and assuring downstream customers that requalification cycles won’t blindside their title batches.
Dosage consistency drives much of our process design. Since mesterolone has a well-defined therapeutic window, batch reproducibility isn’t a marketing detail — it’s central to patient safety. The high-pressure liquid chromatography runs we perform each shift serve as a line-in-the-sand gate; if we don’t hit spec, the batch stops. Any dust or coloring out of spec gets traced to its source, with full logs for customer review.
The uncoated powder form remains the main backbone, but we’ve worked with several partners needing special micronized grades for fast-release matrices. Our ability to tailor bulk density and particle shape to a given project comes both from investment in classification equipment and from operators who pay attention to the “feel” of every blend.
Much is written about technical specs, but we’ve been asked what really counts. For mesterolone, we routinely target a purity above 99% HPLC, with loss on drying never exceeding 0.5%. Residual solvents and trace metals are minimal, confirming to ICH Q3C and Q3D guidance. We batch test microbials and pyrogens at targeted intervals, despite its synthetic origin, particularly because we know how small contaminants can multiply over large-volume tenders.
We’ve watched some outside sources cut corners on drying protocols, giving powder with borderline water activity, which impacts long-term storage and secondary formulations. Our own process runs on vacuum tray driers to lock residuals low, letting packers operate with less worry about caking or moisture-related degradation during shipment. This difference subtly separates us from producers who view specification as a “tick box” rather than a process guarantee.
Odor is another indicator. Real mesterolone, in pure form, has virtually none. Slight bitterness may linger on the tongue, but the material remains otherwise neutral — no sour notes, no burnt hints. Deviations in this profile hint at process errors, contamination, or carry-over from previous runs — an early warning that tells seasoned chemists to halt and verify their lines.
The major generics market doesn’t tolerate irregularity. Our customers rely on predictable particle size for direct compression in their tablet presses, uniformity in reconstitution for blending operations, and repeat behavior in dissolution. We track batch logs back years, syncing the lot consistency with shifts in raw material sourcing, seasonal humidity patterns, and minor tweaks to our reactor loading rates. One lesson learned early: nearly invisible differences in powder “fluff” — what operators call the tactile softness or hardness between batches — become glaring issues on high-speed filling lines. We’ve invested in in-line particle sizing equipment and dryer moisture monitors, simply because variability at this scale can ripple into defective batches and costly scrap down the line.
It goes beyond technology, though. High operator turnover, which hits many “bulk API” plants, increases the risk of misses. We built a program where the same crew specializes on these legacy steroids, logging both parameter data and their own field observations every shift. Pattern recognition becomes part of batch certification; for example, small changes in vacuum stability or the formation of air pockets during slurry discharge signpost adjustments needed, sometimes before instrumentation registers a problem.
Customers occasionally request “pharmacy ready” mesterolone — ultra-low contamination risk, bulk sealed under nitrogen, and traceable through the entire process. Our setup supports this because we don’t outsource key steps, keeping wash and drying lines within one facility for full traceability. The extra attention drives up cost but the reward is zero failed client audits since 2017, and not a single recall rooted in source API irregularity.
From a manufacturing standpoint, comparing mesterolone to related steroids like oxandrolone, metenolone, or stanozolol reveals important process and end-use differences. Mesterolone’s non-alkylated structure simplifies oral dosing, sidestepping the risk of liver toxicity linked to 17-alpha alkylated compounds. Our production runs for mesterolone have fewer environmental red flags; emissions from ether and ketone solvents remain easy to scrub. By contrast, certain derivatives generate more hazardous byproducts, forcing extra abatement layers and tighter environmental reporting.
Mesterolone’s melting point — typically in the 207-210°C range — gives us flexibility for both thermal drying and room-temperature storage. Anabolic cousins with lower melting points sometimes gum up baghouse filters, demanding more frequent line servicing. We found, over years and thousands of kilos, that mesterolone hardly ever sticks to stainless or seals, so process losses stay minimal.
On the analytical side, mesterolone’s UV stability means post-synthesis cleanup requires less rework after exposure to ambient light. Other products in the line risk degradation or isomerization on exposure, reducing shelf life and complicating thermal handling. The ease of stability translates into more reliable shelf stock for our supply-chain partners, who value consistent shelf life under variable shipping conditions across global markets.
Pharmaceutical formulators appreciate mesterolone’s minimal cross-reactivity. In contrast, raw methyltestosterone and certain injectable esters risk batch rework due to incompatibility with standard tableting lubricants or capsule coatings. This difference shows up not only in formulation speed, but in simplified paperwork during regulatory submissions.
The regulatory landscape for synthetic androgens gets stricter every year. We developed our control framework around the latest EudraLex and US FDA guidance, including full electronic batch records, standardized cleaning verification, and periodic environmental monitoring. Any deviation on production floors gets followed up by root cause analysis, not written off as “process variance.” For mesterolone, which often gets produced in shared facilities, cross-contamination risk stays a top focus. Equipment gets swabbed and tested post-batch, and cleaning logs connect every step back to operator, machine, and cleaning cycle.
Traceability isn’t just for the big clients. Even small lots come tagged and fully linked back to the originating raw material shipment, including third-party verification of raw material sources. Mesterolone, unlike some more niche androgens, maintains a strong, well-documented supply trail — vital for partners navigating audits from global regulatory bodies. Our long experience with repeat regulatory inspections has shaped every step, from onboarding new staff to archiving production records for the full required retention period.
Raw material volatility remains a constant reality. Steroid precursors travel a long journey, vulnerable to trade freezes, shipping delays, and fragmented regulatory environments. We anticipated this by locking in alternate supplier contracts, real-time tracking of in-transit goods, and regular quality benchmarking against reference standards. As API manufacturers, we do not shift the risk downstream. Instead, we’ve built extra capacity into aging storage and fine-filtration—so we can buffer production without sacrificing finished batch quality.
The pandemic years taught us the importance of redundancy. Mesterolone runs saw demand spikes, and our in-house team worked overtime to adapt drying cycles and packing schedules across multiple shifts. This response came from embedding flexibility in both process equipment and staff rotation. Unlike trading operations that buy spot lots or outsource key steps, we have upstream command of every synthesis and downstream line, able to intervene in real time if needed.
One less-discussed challenge involves evolving environmental and safety standards. Mesterolone emits few volatile byproducts, but solvent handling, worker exposure, and batch traceability remain under close review year after year. We deployed solvent recovery systems, upgraded containment, and promote open reporting of near-misses or process upsets. This shapes a safety culture that reaches into every shift meeting.
Our direct relationships with clients shape ongoing product evolution. Several years back, one leading generic company reported concerns with reconstitution time and dustiness during bulk powder transfer. This prompted us to add extra sieving and to reevaluate drum liner materials — resolving both the specific complaint and, as we later learned, removing a major source of static buildup during handling. This openness to change, backed by regular site visits and line audits, continues to distinguish our mesterolone product from those from less communicative producers.
Feedback also shapes packaging. Recognizing that different end-users prefer varying pack sizes, we diversified drum and liner offerings — catering both to high-volume formulators and boutique operations requiring smaller aliquots for high-potency compounding. QR-coded traceability on each package, matched to cloud-based batch documents, answers compliance departments’ queries before audits even begin.
The industry leans steadily toward greener, safer production. Mesterolone, by virtue of its robust synthesis and manageable waste streams, fits well in sustainability-driven manufacturing cycles. We recycle process solvents wherever possible. Non-recoverable residues get neutralized on-site in closed-containment reactors, turning out routine compliance with upcoming EU REACH and local groundwater standards long before enforcement deadlines.
Our energy use metrics continue to improve as solar and efficient HVAC upgrades come online. The stability of mesterolone at room temperature allows us to minimize refrigeration demand during storage and transport, making bulk shipments less carbon-intensive than APIs requiring constant cold chain. Waste minimization programs led us to improve our yields every production quarter for the last three years. Each bit of process scrap reduced directly lessens not just chemical waste, but packaging, labor, and shipping inefficiency.
Together with our partner formulators, we invest in lifecycle studies for our product — checking the net environmental burden, including secondary uses and post-expiry waste handling. This approach treats sustainability not as a buzzword, but as a daily discipline that delivers real results in cost, compliance, and environmental stewardship.
With globalization, the demand map for mesterolone spreads across new geographies. Traditional mature markets remain steady, but growth now comes from expanded generic access programs in South America, Southeast Asia, and parts of Africa. We partner with regulators and buyers to assure both high product standard and flexible supply chain arrangements.
Meanwhile, digital transformation reaches even traditional API lines. Our site transitioned to real-time process monitoring, coupling in-line sensors with predictive analytics to identify and address deviation before it escalates. Mesterolone benefits from these systems through sharper batch controls and improved response to anomaly alerts. The net result: stronger consistency, better resource allocation, and a tighter feedback loop for supply forecasting and product improvement.
Our aim is to share both the chemist’s rigor and the manufacturer’s pragmatism in every finished drum — balancing process reliability, customer partnership, and responsible production. New trends in personalized medicine or advanced hormone regulation therapies will likely drive new demand curves. We stand ready, with decades of experience and a workforce skilled in both the science and the art of mesterolone manufacturing.
From our vantage as hands-on chemical manufacturers, the importance of mesterolone goes far beyond product brochures and technical data. Years of practice show that authenticity — from reliable synthesis, to strict process controls, to customer-driven adaptation — creates a product that genuinely serves scientific and public health goals. Those who rely on mesterolone for further formulation or research can count on its consistency, traceability, and practical handling. This simple molecule has proved its worth in every real-world challenge we’ve seen. Combining experience, adaptation, and a culture of quality, our commitment remains fixed: deliver mesterolone that meets both today’s demanding industry needs and tomorrow’s evolving standards.